Sargent Bickham Lagudis LLC Ark Genomic Revolution ETF (De Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 435 shares of ARKG stock, worth $11,697. This represents 0.0% of its overall portfolio holdings.
Number of Shares
435
Previous 435
-0.0%
Holding current value
$11,697
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ARKG
# of Institutions
296Shares Held
20.4MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio